LBA42OpACIN-neo: A multicenter phase II study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO). (23rd October 2018) - Blank, C U; Rozeman, E A; Menzies, A M; van de Wiel, B A; Adhikari, C; Sikorska, K; Krijgsman, O; Eriksson, H; Bierman, C; Grijpink-Ongering, L; Gonzalez, M; Broeks, A; et al.